Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

Pericardial Bioprosthesis Aortic valve replacement with mechanical or biological heart valves is the treatment of choice for aortic valve stenosis when it is symptomatic or with severe aortic ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

JenaValve announced today that it began patient enrollment in the ARTIST study evaluating its Trilogy heart valve system.

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve ...

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

At Sanford Health in Bismarck, doctors have now performed 500 transcatheter aortic valve replacements, known as TAVR.

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say surgeons.

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

The Aortic Annulus Assessment of the anatomy of the aortic annulus is an important component of case selection. [14] Both manufacturers currently have only two sizes of bioprosthesis in widespread ...

Over the past 15 years, the increasing use of echocardiography has dramatically changed our understanding of the prevalence and progression of aortic-valve stenosis. Aortic stenosis may be due to r ...